Ostatní
Návod 
Apellis Pharmaceuticals, Inc.
APLS
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
2.4B
Obrat
1B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
0%
ROA
0%
PE
97
PS
2
Cena 1R
16-31
⌀ Cena
21.90
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
27-02-2026
Poslední dividenda
Profil
Apellis Pharmaceuticals, Inc., biofarmaceutická společnost v komerční fázi, se zaměřuje na objevování, vývoj a komercializaci terapeutických sloučenin prostřednictvím inhibice komplementového systému pro autoimunitní a zánětlivá onemocnění. Hlavním kandidátem na přípravek je pegcetakoplan, který je zařazen do fáze III klinických studií léčby geografické atrofie (GA) u věkem podmíněné makulární degenerace a paroxysmálních nočních hemoglobinurických onemocnění (PNH). Dále se vyvíjí EMPAVELI (systémový pegcetakoplan) pro léčbu studené aglutininové choroby (CAD) a hematopoetické trombotické mikroangiopatie spojené s transplantací kmenových buněk (HSCT-TMA) v hematologii; C3 glomerulopatie (C3G) a imunokomplexní membranoproliferativní glomerulonefritida (IC-MPGN) v nefrologii a amyotrofická laterální skleróza (ALS) v neurologii. Kromě toho společnost vyvíjí APL-2006, což je specifický C3 a VEGF inhibitor pro léčbu poruch zprostředkovaných komplementem; APL-1030, C3 inhibitor pro léčbu mnohočetných neurodegenerativních onemocnění; a kombinaci přípravku EMPAVELI a malé interferující RNA nebo siRNA pro snížení tvorby C3 proteinů játry. Má smlouvu o spolupráci a licenci se švédskou společností Orphan Biovitrum AB (publ) na společném vývoji pegcetakoplanu a výzkumnou spolupráci se společností Beam Therapeutics Inc. zaměřenou na využití technologie Beam pro základní editaci k objevování nových léčebných postupů pro nemoci vyvolané komplementy. Společnost Apellis Pharmaceuticals, Inc. byla založena v roce 2009 a sídlí ve Walthamu ve státě Massachusetts.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
705
Založení
2017-11-09
Podobné společnosti
$ 21.50
+ $ 0.11
$ 38.59
+ $ 0.22
$ 42.88
+ $ 4.86
$ 21.90
- $ 0.31
$ 14.58
- $ 0.21
$ 29.44
+ $ 0.49
$ 30.79
+ $ 0.55
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 1,003.8 | 1,003.8 | 781.4 | 396.6 | 75.4 | 66.6 | 250.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cost of Revenues | 102.7 | 102.2 | 117.7 | 58.5 | 5.6 | 5.2 | 25.1 | 288.0 | 127.9 | 50.8 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 901.1 | 901.5 | 663.6 | 338.1 | 69.8 | 61.4 | 225.6 | -288.0 | -127.9 | -50.8 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 199.9 | 458.6 | 178.5 | 166.8 | 212.5 | 196.8 | 199.7 | 172.3 | 146.4 | 99.2 | |
| Cost of Revenues | 29.7 | 24.5 | 14.1 | 34.4 | 40.9 | 33.6 | 23.5 | 20.7 | 19.9 | 22.4 | |
| Gross Profit | 170.2 | 434.0 | 164.4 | 132.4 | 171.7 | 163.3 | 176.1 | 151.7 | 126.5 | 76.8 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 354.4 | 387.2 | 420.9 | 299.9 | 221.0 | 105.3 | 40.3 | 23.0 | 13.7 | 8.4 | 2.3 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 500.8 | 277.2 | 176.8 | 139.4 | 67.0 | 22.6 | 10.5 | 4.3 | 6.4 | 2.9 | 1.7 | |
| Depreciation & Amortization | 1.6 | 1.6 | 1.8 | 1.7 | 10.1 | 3.3 | 4.3 | 5.2 | 2.9 | 0.0 | 0.0 | 53.0 | 0.0 | 0.0 | |
| Total Operating Expenses | 845.7 | 846.1 | 828.6 | 855.2 | 664.4 | 597.6 | 439.3 | 288.0 | 127.9 | 50.8 | 27.3 | 20.1 | 11.3 | 4.0 | |
| Operating Income | 55.4 | 55.4 | -165.0 | -517.1 | -594.6 | -536.3 | -213.7 | -288.0 | -127.9 | -50.8 | -27.3 | -46.6 | -11.3 | -4.0 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 69.3 | 79.4 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 141.7 | 145.6 | ||
| Depreciation & Amortization | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.5 | 0.4 | ||
| Total Operating Expenses | 221.3 | 210.9 | 197.7 | 215.8 | 197.8 | 210.6 | 205.6 | 213.8 | 211.0 | 225.1 | ||
| Operating Income | -51.1 | 223.2 | -33.3 | -83.3 | -26.2 | -47.3 | -29.4 | -62.1 | -84.5 | -148.3 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 13.1 | 13.1 | 12.8 | 20.9 | 8.9 | 0.4 | 4.2 | 5.1 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 44.3 | 44.3 | 40.4 | 29.6 | 32.6 | 13.2 | 29.9 | 5.3 | 2.5 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | -31.3 | -31.3 | -31.7 | -9.4 | -56.9 | -209.7 | -129.3 | -16.7 | 0.0 | -0.1 | 0.2 | -26.5 | 0.1 | 0.1 | |
| IBT | 24.1 | 24.1 | -196.7 | -526.5 | -651.5 | -746.0 | -343.0 | -304.7 | -127.5 | -51.0 | -27.1 | -46.5 | -11.2 | -4.0 | |
| Income Tax Expense | 1.7 | 1.7 | 1.2 | 2.1 | 0.7 | 0.4 | 1.8 | 5.1 | -0.5 | 0.3 | 0.0 | -26.5 | -0.4 | 0.0 | |
| Net Income | 22.4 | 22.4 | -197.9 | -528.6 | -652.2 | -746.4 | -344.9 | -309.8 | -127.5 | -51.0 | -27.1 | -46.5 | -10.8 | -4.0 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 3.5 | 4.4 | 2.6 | 2.7 | 3.4 | 2.9 | 3.2 | 3.3 | 4.5 | 5.0 | ||
| Interest Expense | 10.8 | 11.3 | 11.2 | 11.0 | 11.5 | 12.5 | 9.4 | 7.0 | 7.4 | 7.3 | ||
| Other Expense | -7.5 | -6.9 | -8.4 | -8.6 | -9.9 | -9.6 | -8.1 | -4.2 | -2.6 | -2.9 | ||
| IBT | -58.6 | 216.3 | -41.7 | -91.9 | -36.1 | -56.9 | -37.5 | -66.3 | -87.2 | -140.0 | ||
| Income Tax Expense | 0.3 | 0.6 | 0.5 | 0.3 | 0.3 | 0.6 | 0.1 | 0.2 | 1.4 | 0.2 | ||
| Net Income | -59.0 | 215.7 | -42.2 | -92.2 | -36.4 | -57.4 | -37.7 | -66.4 | -88.6 | -140.2 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-4.45 | $-8.68 | $-8.84 | $-4.59 | $-4.98 | $-2.34 | $-3.68 | $-1.50 | $-2.57 | $-0.60 | $-0.22 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-4.45 | $-8.68 | $-8.84 | $-4.59 | $-4.98 | $-2.34 | $-3.68 | $-1.50 | $-2.57 | $-0.60 | $-0.22 | |
| Shares Outstanding | 126.0 | 126.0 | 123.9 | 118.7 | 75.2 | 84.4 | 75.2 | 62.2 | 54.4 | 13.9 | 18.1 | 18.1 | 18.1 | 18.1 | |
| Diluted Shares Outstanding | 126.0 | 126.0 | 123.9 | 118.7 | 75.2 | 84.4 | 75.2 | 62.2 | 54.4 | 13.9 | 18.1 | 18.1 | 18.1 | 18.1 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.73 | $-1.17 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.73 | $-1.17 | ||
| Shares Outstanding | 126.0 | 126.0 | 126.0 | 125.5 | 123.9 | 123.9 | 123.9 | 123.0 | 121.2 | 120.3 | ||
| Diluted Shares Outstanding | 126.0 | 126.0 | 126.0 | 125.5 | 123.9 | 123.9 | 123.9 | 123.0 | 121.2 | 120.3 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 361.4 | 411.3 | 351.2 | 551.8 | 640.2 | 565.8 | 352.0 | 176.3 | 175.6 | 24.9 | 36.0 | 13.6 | 4.8 | |
| Short Term Investments | 8.0 | 4.8 | 1.1 | 0.0 | 60.4 | 311.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 361.4 | 416.1 | 352.3 | 551.8 | 700.6 | 877.6 | 352.0 | 176.3 | 175.6 | 24.9 | 36.0 | 13.6 | 4.8 | |
| Accounts Receivable | 308.9 | 271.7 | 206.4 | 7.7 | 10.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.1 | |
| Inventory | 152.8 | 82.5 | 146.4 | 85.7 | 16.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.3 | |
| Other Current Assets | 36.9 | 18.6 | 61.2 | 36.7 | 70.7 | 26.9 | 1.3 | 1.8 | 1.3 | 2.5 | 2.0 | 0.0 | 0.0 | |
| Total Current Assets | 860.0 | 789.0 | 766.3 | 719.5 | 824.0 | 917.2 | 373.1 | 202.4 | 182.0 | 27.4 | 38.0 | 14.2 | 5.2 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 479.2 | 371.5 | 358.4 | 411.3 | 396.9 | 360.1 | 327.0 | 352.3 | 452.4 | 616.3 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 4.8 | 0.0 | 8.0 | 0.0 | 4.4 | 13.1 | 9.4 | |
| Total Cash & ST Investments | 479.2 | 371.5 | 358.4 | 416.1 | 396.9 | 368.0 | 327.0 | 352.3 | 452.4 | 616.3 | |
| Accounts Receivable | 354.6 | 229.2 | 244.4 | 271.7 | 284.0 | 308.9 | 267.8 | 206.4 | 187.0 | 128.3 | |
| Inventory | 122.8 | 121.0 | 82.5 | 82.5 | 121.1 | 162.2 | 161.3 | 146.4 | 98.5 | 103.2 | |
| Other Current Assets | 34.1 | 33.9 | 42.5 | 18.6 | 32.0 | 20.9 | 55.3 | 61.2 | 58.8 | 44.9 | |
| Total Current Assets | 990.7 | 755.6 | 727.7 | 789.0 | 833.9 | 860.0 | 811.4 | 766.3 | 796.8 | 892.7 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 20.2 | 19.0 | 21.1 | 24.9 | 26.1 | 24.5 | 15.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 24.4 | 77.1 | 1.3 | 15.8 | 31.6 | 18.9 | 0.4 | 1.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Total Long-Term Assets | 44.5 | 96.1 | 22.4 | 40.7 | 57.7 | 43.4 | 16.2 | 1.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | |
| Total Assets | 904.5 | 885.1 | 788.7 | 760.2 | 881.8 | 960.6 | 389.2 | 203.5 | 182.1 | 27.4 | 38.2 | 14.3 | 5.2 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 21.6 | 16.8 | 17.8 | 19.0 | 20.4 | 20.2 | 19.2 | 21.1 | 20.3 | 22.1 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 46.4 | 49.0 | 61.8 | 77.1 | 47.5 | 24.4 | 1.3 | 1.3 | 1.2 | 0.8 | |
| Total Long-Term Assets | 68.0 | 65.8 | 79.6 | 96.1 | 68.0 | 44.5 | 20.5 | 22.4 | 21.4 | 22.9 | |
| Total Assets | 1,058.7 | 821.4 | 807.3 | 885.1 | 901.9 | 904.5 | 831.9 | 788.7 | 818.2 | 915.6 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 38.3 | 38.6 | 37.5 | 37.3 | 16.9 | 8.5 | 8.4 | 10.3 | 3.7 | 2.5 | 2.5 | 0.8 | 0.4 | |
| Short-Term Debt | 6.2 | 6.8 | 6.4 | 5.6 | 4.1 | 3.7 | 2.6 | 1.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 122.8 | 140.2 | 203.6 | 124.6 | 7.6 | 4.2 | 54.8 | 5.1 | 2.9 | 1.1 | 0.7 | 0.3 | 0.3 | |
| Current Liabilities | 169.2 | 185.5 | 247.6 | 167.6 | 131.8 | 128.3 | 65.8 | 17.0 | 6.6 | 3.6 | 3.2 | 1.1 | 0.7 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 38.6 | 54.2 | 55.3 | 38.6 | 42.7 | 38.3 | 26.8 | 37.5 | 18.2 | 27.5 | |
| Short-Term Debt | 100.6 | 7.4 | 6.9 | 6.8 | 6.8 | 6.2 | 89.8 | 6.4 | 5.7 | 5.9 | |
| Other Current Liabilities | 140.3 | 139.0 | 116.1 | 140.2 | 139.8 | 124.7 | 95.1 | 203.6 | 161.7 | 141.5 | |
| Current Liabilities | 279.5 | 200.7 | 178.4 | 185.5 | 191.3 | 169.2 | 215.3 | 247.6 | 185.6 | 174.8 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 457.2 | 463.0 | 104.5 | 107.1 | 206.1 | 374.0 | 154.4 | 25.4 | 26.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 11.1 | 17.0 | 17.9 | 20.0 | 21.2 | 18.9 | 14.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 640.2 | 656.5 | 594.2 | 590.3 | 683.1 | 756.0 | 355.0 | 42.6 | 33.2 | 3.6 | 3.2 | 1.1 | 0.7 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 374.8 | 462.3 | 462.6 | 463.0 | 463.7 | 468.3 | 102.9 | 104.5 | 103.8 | 104.9 | |
| Capital Leases | 20.7 | 7.4 | 16.1 | 17.0 | 18.2 | 17.3 | 9.8 | 11.5 | 16.6 | 17.9 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 657.6 | 665.1 | 643.1 | 656.5 | 664.7 | 640.2 | 565.3 | 594.2 | 585.9 | 570.2 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -2,941.6 | -3,035.4 | -2,837.5 | -2,308.9 | -1,656.7 | -926.3 | -581.5 | -276.8 | -149.3 | -98.3 | -71.1 | -24.6 | -13.8 | |
| Comprehensive Income | -3.4 | -3.3 | -3.5 | -0.9 | -2.1 | -0.1 | -0.2 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 264.3 | 228.5 | 194.5 | 169.9 | 198.7 | 204.6 | 34.2 | 161.0 | 148.9 | 23.8 | 35.0 | 13.2 | 4.5 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -2,954.0 | -3,169.7 | -3,127.6 | -3,035.4 | -2,999.0 | -2,941.6 | -2,903.9 | -2,837.5 | -2,748.9 | -2,608.7 | |
| Comprehensive Income | -2.4 | -2.6 | -3.1 | -3.3 | -3.1 | -3.4 | -3.5 | -3.5 | -1.1 | -0.8 | |
| Total Common Equity | 401.2 | 156.3 | 164.2 | 228.5 | 237.1 | 264.3 | 266.7 | 194.5 | 232.3 | 345.4 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 474.5 | 469.8 | 110.9 | 112.7 | 210.2 | 377.7 | 157.0 | 27.0 | 26.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 264.3 | 228.5 | 194.5 | 169.9 | 198.7 | 204.6 | 34.2 | 161.0 | 148.9 | 23.8 | 35.0 | 13.2 | 4.5 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 401.2 | 156.3 | 164.2 | 228.5 | 237.1 | 264.3 | 266.7 | 194.5 | 232.3 | 345.4 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -332.9 | 22.4 | -197.9 | -528.6 | -652.2 | -746.4 | -344.9 | -304.7 | -127.5 | -51.0 | -27.1 | -46.5 | -10.8 | -4.0 | |
| Depreciation & Amortization | 1.8 | 0.0 | 1.8 | 1.7 | 1.5 | 1.5 | 0.6 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Stock-Based Compensation | 108.2 | 0.0 | 114.1 | 105.9 | 91.1 | 70.7 | 45.4 | 21.1 | 7.7 | 5.4 | 1.1 | 0.5 | 0.7 | 0.3 | |
| Change Working Capital | -209.7 | -85.1 | -18.4 | -200.2 | -15.7 | -93.5 | 19.6 | 53.1 | -12.0 | -1.2 | 0.0 | 0.6 | 0.2 | 0.2 | |
| Change In Accounts Receivable | -193.5 | -101.3 | -58.5 | 0.0 | 2.4 | -10.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | 10.8 | 18.2 | 1.1 | 0.2 | 18.7 | 10.5 | -0.1 | -1.6 | 6.6 | 0.9 | 0.1 | 1.7 | 0.4 | 0.2 | |
| Change In Inventories | -72.6 | -15.3 | -10.8 | 0.0 | -69.4 | -16.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 213.2 | 108.1 | 12.4 | 26.4 | 61.6 | 6.3 | 15.8 | 2.7 | 0.6 | 0.0 | 0.0 | 26.5 | 0.0 | 0.3 | |
| Cash from Operations | -408.3 | 0.0 | 0.0 | -594.7 | -513.7 | -563.1 | -160.5 | -211.1 | -131.2 | -46.6 | -26.0 | -18.9 | -9.9 | -3.4 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -81.3 | 215.7 | -42.2 | -92.2 | -36.4 | -57.4 | -37.7 | -66.4 | -88.6 | -140.2 | |
| Depreciation & Amortization | -1.2 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.5 | 0.4 | |
| Stock-Based Compensation | -82.8 | 28.2 | 27.2 | 27.4 | 0.0 | 27.5 | 30.0 | 30.3 | 26.2 | 21.6 | |
| Change Working Capital | 22.5 | -136.4 | 18.3 | 10.4 | 28.4 | 62.8 | -6.2 | -103.5 | -42.6 | -57.5 | |
| Change In Accounts Receivable | -20.7 | -131.4 | 21.1 | 29.7 | 14.1 | 25.4 | -36.6 | -61.4 | -37.2 | -58.4 | |
| Change In Accounts Payable | 18.2 | -15.6 | -1.0 | 16.7 | 1.5 | -1.2 | 11.5 | -10.7 | 19.6 | -9.6 | |
| Change In Inventories | -8.7 | 5.4 | -26.0 | 14.0 | 10.0 | 8.7 | -14.5 | -14.9 | -47.8 | 4.7 | |
| Other Non-cash Items | 128.6 | 0.6 | 0.6 | 0.6 | 26.9 | 0.8 | 5.1 | 6.1 | 6.7 | 6.5 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -97.9 | -169.1 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.5 | -0.3 | -0.4 | -0.8 | -1.5 | -1.1 | -5.4 | -1.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Acquisitions | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | -331.9 | -171.3 | -879.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 393.3 | 420.0 | 567.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -0.4 | 0.0 | 0.0 | -0.7 | 59.9 | 247.6 | -317.0 | -1.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.2 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -0.3 | -0.1 | 0.0 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -160.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -28.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | |
| Debt Issued | 524.3 | 469.8 | 358.9 | -1.8 | -97.5 | -167.5 | 220.7 | 158.7 | 0.7 | 26.4 | 0.0 | 0.0 | 0.0 | 0.3 | |
| Issuance of Common Stock | 47.5 | 0.0 | 0.0 | 384.4 | 380.1 | 380.4 | 381.4 | 109.6 | 131.2 | 150.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 4.2 | 3.0 | 1.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | -1.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -227.5 | 0.0 | 0.0 | 10.1 | -18.7 | 8.9 | 309.2 | 307.7 | 0.7 | 47.3 | 14.9 | 41.2 | 18.8 | 7.4 | |
| Cash from Financing | 152.5 | 0.0 | 0.0 | 394.5 | 365.7 | 392.2 | 692.2 | 388.5 | 131.9 | 197.4 | 14.9 | 41.2 | 18.8 | 7.2 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 475.4 | 5.6 | 0.2 | -0.2 | -0.7 | -4.1 | 281.8 | 81.8 | 1.4 | -1.2 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 27.1 | 5.8 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.6 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.4 | 5.7 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.9 | 5.7 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -255.9 | 55.1 | 60.3 | -200.8 | -88.7 | 74.7 | 215.1 | 175.7 | 0.6 | 150.8 | -11.1 | 22.4 | 8.9 | 3.7 | |
| Closing Cash Balance | 361.4 | 467.8 | 412.6 | 352.3 | 553.1 | 641.8 | 567.0 | 352.0 | 176.3 | 175.6 | 24.9 | 36.0 | 13.6 | 4.8 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -12.8 | 109.1 | 11.6 | -52.8 | 14.4 | 36.8 | 34.4 | -25.3 | -101.2 | -163.8 | |
| Closing Cash Balance | 467.8 | 480.6 | 371.5 | 359.8 | 412.6 | 398.2 | 361.4 | 327.0 | 352.3 | 453.5 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -408.8 | 45.0 | -88.3 | -595.5 | -515.3 | -564.2 | -165.9 | -212.8 | -131.2 | -46.6 | -26.0 | -18.9 | -10.0 | -3.4 | |
| Real Free Cash Flow | -517.0 | 45.0 | -202.4 | -701.5 | -606.4 | -634.9 | -211.3 | -234.0 | -139.0 | -52.0 | -27.1 | -19.4 | -10.6 | -3.7 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -14.0 | 108.3 | 4.4 | -53.4 | 19.3 | 34.1 | -8.4 | -133.3 | -98.0 | -169.1 | |
| Real Free Cash Flow | 68.8 | 80.1 | -22.8 | -80.8 | 19.3 | 6.6 | -38.4 | -163.6 | -124.2 | -190.8 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 96.9 | -6.1 | -1.4 |
| P/S | 2.2 | 25517.2 | 9.4 |
| P/B | 5.4 | 15.1 | 5.2 |
| P/FCF | 47.8 | -31.4 | -1.5 |
| Market cap | $2.4 | $4.0 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 22.1 % | 0 % |
| Debt to Income | 2123.3 % | -20.3 % | 0 % |
| Debt to Free cash flow | 1048.8 % | -244.7 % | 0 % |
| Interest expense percentage | 80 % | -4.6 % | 44.7 % |
| Current ratio | 3.5 | 8.1 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 5.6 % | -142.6 % | 0 % |
| ROA | 2.1 % | -58.4 % | 0 % |
| CapEx to Revenue | 0 % | 681.4 % | 0 % |
| RaD to Revenue | 0 % | 158695.4 % | 0 % |
| ROEM | 1,423,804.3 | 124206.2 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 85.2 % | -145481.7 % | 68.7 % |
| Operating margin | 8 % | -195042.7 % | 35.5 % |
| Net margin | 3.2 % | -196634.5 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | -0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 0.0 tis | 72.1 mil |
| Employee count | 0.7 tis | 0.4 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
